Strides Pharma Science Limited, headquartered in Bangalore, India, is a pharmaceutical company specializing in the development and manufacture of niche generic products. The company’s product portfolio includes soft and hard gelatin capsules, tablets, oral liquids, powders, topicals, ointments, and creams. Strides operates 15 manufacturing facilities across six countries and markets its products in over 100 countries.

The company collaborates with generic pharmaceutical firms to supply retail and hospital generics, particularly in injectable products and softgels. Additionally, Strides is actively involved in international initiatives to combat diseases like HIV/AIDS, tuberculosis, and malaria, partnering with organizations such as the Clinton Foundation and the World Health Organization to provide cost-effective medications.

In recent developments, Strides Pharma Global, a subsidiary of Strides Pharma Science, received approval from the U.S. Food and Drug Administration in January 2025 for its generic Acetaminophen and Ibuprofen tablets, expanding its product offerings in the U.S. market.

With a workforce of over 3,000 employees, Strides Pharma Science continues to focus on innovation and quality, reinforcing its position as a key player in the global pharmaceutical industry

Address: No.19/1, 19/3, Alibommasandra, Muttanalluru Post, Sarjapura Hobli, Anekal Taluk, Bengaluru, Karnataka 560099